Invenra Inc., a U.S.-based biotechnology company pioneering multispecific antibody platform technologies, and Xcellon Biologics, a wholly owned subsidiary of Linden Lake Labs and a U.S.-based contract ...
PEGylation and glycosylation as bioconjugation tools for drug development: New webinar tackles complex chemistry for targeted ...
Salubris Biotherapeutics, Inc. (SalubrisBio), a clinical-stage biotechnology company dedicated to discovering and developing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback